The Romanian Competition Council has concluded an investigation into Sun Wave Pharma, a subsidiary of an Indian company, and found that it engaged in unfair competition practices. The company was found to have pressured Geltec Private, an Indian manufacturer, to stop delivering food supplements to Bleu Pharma, a competitor in the Romanian market. This action was deemed to be a contravention of honest practices and had a negative impact on the business environment, destabilizing the activity of market players.
The investigation was launched in 2024 after Bleu Pharma notified the Competition Council of the alleged unfair practices. An unannounced inspection was carried out at the headquarters of Sun Wave Pharma as part of the analysis. The Competition Council has prohibited Sun Wave Pharma from using such practices and has stated that the affected company, Bleu Pharma, can seek compensation through the courts.
According to Law 11/1991 on combating unfair competition, the Competition Council has the authority to order measures to prohibit unfair acts and issue decisions that allow harmed companies to seek compensation. The president of the Competition Council, Bogdan Chirițoiu, stated that the decision aims to promote honest practices and a stable business environment.
The ruling is significant as it highlights the importance of fair competition in the Romanian market. The Competition Council’s decision demonstrates its commitment to protecting companies from unfair practices and promoting a level playing field. Bleu Pharma can now seek compensation for any damages suffered as a result of Sun Wave Pharma’s actions, and the decision may serve as a deterrent to other companies engaging in similar practices. The case is a reminder of the importance of complying with competition laws and regulations to ensure a healthy and competitive business environment.